LS
Lakhi Shaw
About Lakhi Shaw
Data last updated:
Lakhi Shaw has 12 years in corporate governance. Holds Director role. Currently with 2 companies, including Lancet Pharmamed Private Limited and Palger-Q Trading Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Palger-Q Trading Private Limited at ₹18.07 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Palger-Q Trading Private Limited U51909WB2014PTC200469 | Director | 25 Feb 2014 | 2014 | ₹18.07 Cr (FY 2025) | Active |
| Lancet Pharmamed Private Limited U46497WB2024PTC268110 | Director | 05 Feb 2024 | 2024 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Lakhi Shaw
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lakhi Shaw
Lakhi Shaw has 12 years in corporate governance. Holds Director role. Currently with 2 companies, including Lancet Pharmamed Private Limited and Palger-Q Trading Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Palger-Q Trading Private Limited at ₹18.07 Cr (FY 2025).
Lakhi Shaw is associated with 2 companies as Director, including Palger-Q Trading Private Limited (₹18.07 Cr), Lancet Pharmamed Private Limited.
Lakhi Shaw has expertise in General Business.
Lakhi Shaw has 12 years in corporate governance.
By reported revenue, the largest current company of Lakhi Shaw is Palger-Q Trading Private Limited, with revenue of ₹18.07 Cr (FY 2025).
Lakhi Shaw currently holds positions at 2 companies: Palger-Q Trading Private Limited (₹18.07 Cr), Lancet Pharmamed Private Limited.